Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
24,175,022
-
Shares change
-
+174,320
-
Total reported value, excl. options
-
$92,584,064
-
Value change
-
-$11,019,460
-
Put/Call ratio
-
81%
-
Number of buys
-
29
-
Number of sells
-
46
-
Price
-
$3.83
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2018
As of 31 Dec 2018 Arbutus Biopharma Corp - Common Shares, without par value (ABUS) had 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,175,022 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, PRIMECAP MANAGEMENT CO/CA/, EcoR1 Capital, LLC, BlackRock Inc., LADENBURG THALMANN FINANCIAL SERVICES INC., Foresite Capital Management IV, LLC, MORGAN STANLEY, BANK OF MONTREAL /CAN/, Hudson Bay Capital Management LP, and STATE STREET CORP.
This table shows 103 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.